Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Izmir
Clinical trial register · Turkey

Clinical Trials in Izmir, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Ankara 30 Istanbul 25 Izmir 19 Adana 12 Bursa 5
Narrow the registerReset
Recruitment status
Phase
Site location
Ankara30 Istanbul25 Izmir19 Adana12 Bursa5
All 28 locations
Target enrolment
to

Trials with a site in Izmir

19 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Amgen
Phase 1
160
Adana, Ankara, Izmir
2026-04-21
Active, closed
Amgen
Phase 3
350
Ankara, Istanbul, Izmir, Sakarya
2025-08-18
Recruiting
Amgen
Phase 3
12,800
Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Denizli, Istanbul, Izmir
2025-07-25
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Afyonkarahisar, Ankara, Çorum, Istanbul, Izmir, Kayseri, Kocaeli, Konya
2025-06-25
Active, closed
Amgen
Phase 2
252
Adana, Ankara, Istanbul, Izmir
2025-02-26
Active, closed
Amgen
Phase 3
563
Ankara, Istanbul, Izmir, Mersin, Sakarya
2024-06-05
Active, closed
Amgen
Phase 3
111
Ankara, Istanbul, Izmir, Trabzon
2024-04-22
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Ankara, Istanbul, Izmir, Kocaeli, Mersin, Samsun
2024-02-20
Active, closed
Amgen
Phase 3
633
Yenimahalle/Ankara, Kadıköy, Adana, Ankara, Bursa, Gaziantep, Istanbul, Izmir
2023-11-02
Active, closed
Amgen
Phase 3
509
Ankara, Denizli, Istanbul, Izmir, Malatya
2023-05-31
Active, closed
Amgen
Phase 3
303
Ankara, Antalya, Istanbul, Izmir, Samsun
2021-11-02
Recruiting
Amgen
Phase 3
60
Ankara, Istanbul, Izmir, Kayseri
2021-09-09
Active, closed
Amgen
Phase 1/2
181
Ankara, Istanbul, Izmir
2021-01-04
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
Amgen
Phase 3
238
Ankara, Izmir, Kocaeli
2020-10-15
Active, closed
Amgen
Phase 3
145
Ankara, Denizli, Edirne, Istanbul, Izmir, Kocaeli, Konya, Malatya
2020-02-26
Recruiting
Amgen
Phase 3
56
Ankara, Elâzığ, Istanbul, Izmir, Kayseri
2019-04-29
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/izmir

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Izmir that also match the filters currently applied.

How many clinical trials are recruiting in Izmir?

7 of the 19 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Izmir), 19 studies
PhaseStudiesRecruitingShare
Phase 316684.2%
Phase 1115.3%
Phase 1/2105.3%
Phase 2105.3%

Most active sponsors

Lead sponsors with the most studies (Izmir)
Lead sponsorStudiesRecruiting
Amgen197
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.